EDGAR Filing Documents for 0001179110-17-010769

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001179110-17-010769

Filing Date

2017-07-28

Accepted

2017-07-28 16:03:25

Documents

Period of Report

2017-07-27

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4 -	edgar.html	4
1	FORM 4 -	edgar.xml	4	3850
	Complete submission text file	0001179110-17-010769.txt		5261

Mailing Address CRITICAL THERAPEUTICS INC 60 WESTVIEW STREET LEXINGTON MA 02421

Business Address

Type: 4 | Act: 34 | File No.: 001-37467 | Film No.: 17989996

Mailing Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139

Business Address ONE KENDALL SQUARE BLDG. 1400E, SUITE B14202 CAMBRIDGE MA 02139 617-349-1971

CATABASIS PHARMACEUTICALS INC (Issuer) CIK: 0001454789 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations